MedTrace Logo

Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome

NCT04283292 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-10-18

No results posted yet for this study

Summary

This study aims to determine if capsaicin cream offers symptomatic relief to patients suffering from Cannabinoid Hyperemesis Syndrome (condition that leads to repeated and severe bouts of vomiting).

Conditions

  • Cannabinoid Hyperemesis Syndrome

Interventions

DRUG

Capsaicin

Topical Capsaicin for the treatment of Cannabinoid Hyperemesis Syndrome

DRUG

Placebo

Placebo cream that is applied once topically

Sponsors & Collaborators

  • University of Virginia

    lead OTHER

Principal Investigators

  • Angela Holian, PharmD · University of Virginia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-03-18
Completion
2022-03-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04283292 on ClinicalTrials.gov